• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3851
Device Problems Break (1069); Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/12/2021
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that shaft break occurred.The de novo target lesion was located in the obtuse marginal branch.A 2.75 x 10mm wolverine cutting balloon was advanced but due to fibrocalcified plaque, the device would not cross the lesion.When the physician tried to negotiate, the shaft broke.The procedure was completed with a non compliant balloon.There were no complications reported and the patient condition following the procedure was stable.
 
Event Description
It was reported that shaft break occurred.The de novo target lesion was located in the obtuse marginal branch.A 2.75 x 10mm wolverine cutting balloon was advanced but due to fibrocalcified plaque, the device would not cross the lesion.When the physician tried to negotiate, the shaft broke.The procedure was completed with a non compliant balloon.There were no complications reported and the patient condition following the procedure was stable.It was further reported that the 80% to 90% stenosed target lesion was located in the moderately calcified and mildly tortuous obtuse marginal branch.The shaft fragment was retrieved by manually removing it from the guide.It was noted that a 6f guide catheter was used during the procedure.Significant resistance was encountered while navigating the device.
 
Manufacturer Narrative
A2 age at time of event: 18 years or older.Device evaluated by mfr: a 10mm x 2.75mm wolverine cutting balloon mr was returned for analysis.A visual examination identified that the balloon folds were wrapped.No issues were noted with the balloon of the device that may have potentially contributed to the complaint incident.The markerbands and blades and tip section of the device were visually and microscopically examined, and no issues were noted with the markerbands, blades or tip of the device that may have potentially contributed to the complaint incident.All blades were present and fully bonded to the balloon material.A visual and tactile examination found that the device was received in two sections as a result of a break in the hypotube.The break was located at 20.9cm distal from the distal end of the strain relief.Hypotube kinks were also noted.A visual and tactile examination of the extrusion shaft found no issues with the extrusion shaft.No other issues were identified during the product analysis.
 
Manufacturer Narrative
A2 age at time of event: 18 years or older.
 
Event Description
It was reported that shaft break occurred.The de novo target lesion was located in the obtuse marginal branch.A 2.75 x 10mm wolverine cutting balloon was advanced but due to fibrocalcified plaque, the device would not cross the lesion.When the physician tried to negotiate, the shaft broke.The procedure was completed with a non compliant balloon.There were no complications reported and the patient condition following the procedure was stable.It was further reported that the 80% to 90% stenosed target lesion was located in the moderately calcified and mildly tortuous obtuse marginal branch.The shaft fragment was retrieved by manually removing it from the guide.It was noted that a 6f guide catheter was used during the procedure.Significant resistance was encountered while navigating the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key12193386
MDR Text Key262434610
Report Number2134265-2021-09245
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 08/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/30/2023
Device Model Number3851
Device Catalogue Number3851
Device Lot Number0027061248
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/03/2021
Date Manufacturer Received08/24/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-